The Aevolve Team

Rogelio Santos, Jr.

Rogelio Santos, Jr., otherwise known as “Vonz”, is the Founder and CEO of cutting-edge biotech company Amylex. Amylex is at the forefront in the use of nanomolecular tech innovation for the medical treatment of Alzheimer’s disease and diabetes. He has led Amylex’s flagship product through its initial R&D stages onto clinical trials and FDA approval.

Hailed as a technology prodigy, he sold his first software at a young age of eight (8) and has become an international software consultant for major companies. Today his latest efforts are in the blockchain space, moving towards creating new assets that bridge the gap between the worlds of biotech innovation and the exponential benefits of blockchain technology.

Michelle Varron

Michelle Varron is a blockchain and cryptocurrency entrepreneur. She is known to be one of the earliest entrepreneurs in the Philippines’ crypto space and a bitcoin advocate since 2012. She has been instrumental in various crypto and blockchain projects, including wallets and payment processors, remittance engines, exchanges, bespoke and enterprise blockchains. She is co-founder of a blockchain tech provider and CSO/partner at a crypto exchange with offices in the Philippines and Silicon Valley.

Her current efforts are geared towards the next stage of crypto and blockchain models, focused on new cryptoasset creation for institutional clients, decentralized enterprise platforms and new ecosystems for healthcare. She is also a biologist working towards a combined M.D./PhD, technical writer for the medical field and publication editor.

Mark Chester

Mark Chester is a globally-recognized executive with extensive experience of the life science and medical device industries. He specializes in leading organizations through major transformations related to Blockchain, Digital Transformation and ERP programs. Mark has held global executive roles with industry leading firms including Novartis, Ernst & Young and Sony. Today he leads the IT Advisory firm Ley-Line Advisory, Inc. as its CEO.

With over 30 years in complex global transformational programs, Mark has guided some of the largest business transformations in the world including various large divestitures and mergers. He has many recognitions including – Top 30 Top 30 Fastest Growing Private Companies to Watch 2018, Winner of the Best & Brightest 2018 and nominated for 2018 Entrepreneur of the year and Best in Customer Service.

Johnathan Stanley

Johnathan Stanley is an entrepreneur who specializes in consulting with early-stage companies to determine their valuation and guide them towards profitability. Johnathan has founded and successfully sold multiple companies including a nationwide real estate title company. He is nationally known and sought after in a variety of fields including business development, biotech fundraising, cryptocurrency development and land acquisition for Fortune 500 companies such as Sprint, A&T and General Dynamics.

Brendan Sturm

Brendan Sturm is a talented blockchain expert specializing in smart contract development, technical advising and product strategy. He has extensive experience helping teams design and build decentralized applications and has immersed himself in the blockchain space by founding active blockchain meetup groups in Washington DC. Some of Brendan’s previous projects include helping Cord design a smart contract based advertising exchange, building and deploying Uncloak’s token and crowdsale, and creating a tokenomic model for Atrium, a decentralized micro-task marketplace.

He served as co-founder and CTO of Ledger Capital, a cryptocurrency trading firm, and worked at Capital One creating, designing and implementing sophisticated fraud defenses. Brendan graduated from Washington University in St. Louis, studying computer science and economics.

Richard Lipkin

Richard Lipkin is a quantitative scientist with experience in coding and data analysis in various fields. His diverse strengths include technical writing, editing and project management. He has worked on computational molecular biophysics, neuroscience, brain imaging and biological psychiatry which has been highlighted in seven (7) peer-reviewed publications.

He earned his PhD in chemistry (Computational Molecular Biophysics) and is focusing on molecular simulation programming. He is interested in data science, machine learning, blockchain and distributed ledger technology.

Guillermo Tous, PhD

Senior Director of Biopharmaceutical and Pharmaceutical Research and Development with 25 year track record managing and prioritizing multiple simultaneous projects. Served six years as Senior Director for Product Development, Process Development, Formulation Development, Analytical Science, Chemical Development and Protein Development at Stiefel, a GSK company, Barrier Therapeutics and Phyton Biotech, Inc.; five years as Director of Chemistry, Protein Development; and Analytical Biochemistry Research and Development at Phyton Biotech, Inc and MedImmune Inc.; and seven years as Manager of Chemical Development, Analytical Services (CDAS, with overall responsibilities for cGMP compliance and FDA interactions for SNDA filings), and registration services at Bristol-Myers Squibb.

Eustaquio De Ocampo Abay II, MD

Dr. Eustaquio Abay is the founder of Abay Neuroscience Center beginning as a solo practice in 1986 and emerging to become the largest neurosurgery practice in the greater Wichita metropolitan area serving patients nationwide. Dr. Abay is a leading expert and practicing neurosurgeon. Currently serving on several boards in the healthcare, corporate, and non- profit sectors, he was named by Money Magazine as one of the top surgeons of the United States.

Charles Athle Nelson

Charles Athle Nelson is the Managing Director at Murdock Capital Partners. He has been active in the capital markets for the past 35 years. He began his financial career as a market representative with American International Group and in 1978 joined Dean Witter Reynolds as a Financial Advisor, working with high net-worth and institutional clients. In 1980, he joined Drexel Burnham Lambert, and subsequently, at Ladenberg, Thalmann, Auerbach Pollack and Richardson originating equity and investment banking transactions. He is responsible for advisory, merchant banking and general business developments for the Pacific Basin and Austral Asian markets.

He holds a BA from Villanova University and an MBA from Rutgers University. For the last 10 years, Charles has been focusing primarily on life science, specifically in early stage biotech and medical device companies.

Tatiana Ovchinnikova

Tatiana Ovchinnikova is a dynamic leader, entrepreneur, quantitative analyst and mathematician currently focused on blockchain technology and fintech. Co-investment, partnership, strategic development, and technology are her areas of expertise. She is an advisor for several successful ICOs and STOs, holding a Masters in applied mathematics, MBA finance, AI and Data Science degrees from leading universities.

Tatiana ran several international startups and was a sales executive for a telecom technology company and a macroeconomist for the United Nations (UN). Her multidisciplinary cross domain expertise enabled her to become a strong and robust strategist to take companies to new levels in stress management and in their overall evolution.

Tom Eineker

Tom Eineker is an executive visionary known for delivering high-value ROI for SAP consulting services. His expertise includes strategy, execution and optimization of operational support services. Over the last 25 years, his accomplishments include implementation of SAP best practices and customized solutions for over 500 of the world’s industry-leading Global 2000 clients.

Tom is currently working on digital transformation blockchain projects for various clients, offering end-to-end services that include strategic advisory, technology, use cases, development of proof-of-concept (POC), and consulting on ICO whitepapers.

Paul Feldman

Paul Feldman is CEO of one of the largest online and print B2B media companies in the insurance and financial services industry. With over 25 years of industry and media experience, Paul works with and consults for some of the world’s largest insurance companies and marketing organizations. Paul’s main passion is in the art and science of advertising, marketing and sales.

Liam Glennon

Liam Glennon is an entrepreneur, consultant, investor, innovation architect in the blockchain industry. He currently architects blockchain-based solutions across industries including healthcare, video games, supply chain and sustainability. He is a co-founder of multiple blockchain-focused startups and provides services to enterprise-level clients where he helps companies build new decentralized business models with token, distributed ledger and connected technology solutions.

Some of his past activity includes creating a second-gen blockchain game called CryptoPets, winning the Consensus 2017 Building Blocks Hackathon and strategic advisory for digital asset projects. Previously, he was a consultant specializing in forensic accounting and litigation support.

Peter Hans Frederikse, PhD

Dr. Peter Hans Frederikse is an Associate Professor of the Department of Oral Biology at the RBHS Dental School. He completed his Doctorate Degree in Microbiology at the University of Maryland in 1985. After which, he received his Post-Doctoral Fellowship in Molecular Microbiology from the Columbia University College of Physicians & Surgeons in 1989. He has received various awards and honors for his work such as the the Young Investigator Award in 1988, the National Foundation for Eye Research Award in 1995, and the International Society for Eye Research Fellowship Award in 1996. He was also named Associate Editor of the “Journal of Alzheimer’s Disease” in 2012. He has a considerable number of patents under his name, most of which are focused on ophthalmic health concerns and Alzheimer’s Disease.

Chinnaswamy Kasinathan, PhD

Dr. Kasinathan is an Associate Professor in the Department of Oral Biology at the University of Medicine and Dentistry of New Jersey. He received his Doctorate Degree at the Postgraduate Institute of Medical Education and Research in Chandigarh, India in 1984. He completed his postdoctoral training in the Department of Physiology and Biophysics at Mount Sinai School of Medicine in New York before joining the Department of Oral Biology at New Jersey Dental School in 1988.